Related Experiment Videos
Malignant mediastinal germ cell tumors: an intergroup study.
D Billmire1, C Vinocur, F Rescorla
1Division of Pediatric Surgery, St Christopher's Hospital for Children, Philadelphia, PA, USA.
Journal of Pediatric Surgery
|January 11, 2001
Summary
Malignant mediastinal germ cell tumors (MGCT) are rare pediatric neoplasms. Aggressive surgical resection, even after chemotherapy, offers a significant survival rate, especially for younger patients.
Area of Science:
- Pediatric Oncology
- Medical Genetics
- Tumor Biology
Background:
- Malignant mediastinal germ cell tumors (MGCT) are rare pediatric neoplasms.
- Understanding their clinical characteristics and treatment response is crucial for improving outcomes.
Purpose of the Study:
- To determine the clinical characteristics of MGCT in children.
- To evaluate the response to various therapeutic strategies, including chemotherapy and surgical resection.
Main Methods:
- Secondary analysis of a randomized trial (POG 9049/CCG 8882) focusing on patients with primary mediastinal germ cell tumors.
- Review of clinical and operative findings, treatment protocols, and survival data.
Main Results:
- Thirty-six patients with MGCT were analyzed; 34 had anterior mediastinal tumors.
- Histologies varied, with yolk sac tumor common in girls and mixed elements in boys.
- Overall 4-year survival was 71%, with 26 of 36 patients surviving.
- Boys aged 15 years or older showed higher mortality from tumor progression.
Conclusions:
- MGCT is a complex tumor with diverse histology and frequent benign elements.
- Chemotherapy alone often results in incomplete tumor regression.
- Complete surgical resection, whether at diagnosis or post-chemotherapy, is recommended for optimal survival.
- Adolescent boys represent a high-risk subgroup requiring intensified treatment strategies.